Thermo Fisher Scientific

Keeping tests close to home allows the lab and the clinic to work closely together

The power of in-house genomic profiling is felt by both patient and pathologist

Keeping molecular testing in-house offers benefits for pathologists, oncologists, and patients

Panel discussion highlights the benefits of keeping it close

As the UK heads toward test centralization, medical oncologist Tanya Ahmad explains why in-house testing shouldn’t be left behind

In-house testing offers labs the ability to research, educate, and achieve complete coordination with clinical colleagues

A comparison of commonly used NGS assays for the detection of fusion genes based on a recent educational webinar

An interview with Ruthy Shaco-Levy to explore why in-house laboratory is a valuable resource for both clinicians and patients

Oncologist and clinical researcher Elena Garralda shares her opinion on the benefits of rapid turnaround times for next-generation sequencing results

How valuable can it be to receive fully automated NGS results in a single day? A group of experts share their views